Our analysis revealed a strong impact of antivirals (Avs) 5BVdU + IFN-α on HSV-1 infection during days 3 to 7 post-infection, with the most significant results observed on day 7, where infected NPCs exposed to the antiviral had a minimal number of viral transcripts (Figs. 2b and 3). The gene discussed is IFNA1; the disease is infection.